Again, the point of the hearing is how do we maintain quality, how do we encourage the pharmaceutical sector to innovate and take some risks, but how do we get a handle on the enormous cost of providing drugs to Americans.
Udall highlights the need to balance drug quality, innovation, and costs.
Share
More from Mark Udall
General Shelton, does the Air Force currently have a need for those satellite launches?
today is a historic day, as Senator Wyden made clear, Senator Feinstein, Senator Rockefeller, and many other Senators to follow. Before I talk about my involvement in the efforts that were put forth to reach this day, I want to say to…
We are grateful to Senators Udall and Barrasso as well as the bipartisan co-sponsors of S. 2440.
Other voices in this conversation
